ADVFN Logo ADVFN

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

SPRO Spero Therapeutics Inc

0.8601
0.00 (0.00%)
28 Mar 2025 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Rendering Error
Year End 31 December 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 335k1.98M3.97M18.15M9.33M18.26M53.51M103.78M
Operating Income -33.22M-41.73M-42.81M-63.22M-79.11M-87.97M-42.2M26.79M
Pre Tax Income -32.64M-39.89M-41.66M-60.93M-78.28M-89.76M-46.42M25.4M
Net Income -29.93M-46.1M-41.66M-60.93M-78.28M-89.76M-46.42M22.81M
Preferred Dividends -4.44M-6.15M000000
Basic Earnings Per Share (EPS) -89.337-3.208-2.421-3.175-2.675-2.77-0.8850.43
EBIT -33.22M-41.73M-42.81M-62.48M-78.68M-88.37M-45.83M26.77M
EBITDA -32.92M-41.37M-42.4M-62.47M-78.35M-87.33M-41.5M27.15M